JP5814242B2 - 新規なヘパリン体とその利用法 - Google Patents
新規なヘパリン体とその利用法 Download PDFInfo
- Publication number
- JP5814242B2 JP5814242B2 JP2012529895A JP2012529895A JP5814242B2 JP 5814242 B2 JP5814242 B2 JP 5814242B2 JP 2012529895 A JP2012529895 A JP 2012529895A JP 2012529895 A JP2012529895 A JP 2012529895A JP 5814242 B2 JP5814242 B2 JP 5814242B2
- Authority
- JP
- Japan
- Prior art keywords
- heparin
- substrate
- medical
- heparinase
- substrate according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
- A61L33/128—Other specific proteins or polypeptides not covered by A61L33/122 - A61L33/126
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
Description
この実施例では、ヘパリンと、コアとしての硫酸コリスチンとを含むヘパリン体の構成を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
この実施例では、ヘパリンと、コアとしての硫酸ネオマイシンとを含むヘパリン体の構成を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
この実施例では、ヘパリンと、コアとしての硫酸カプレオマイシンとを含むヘパリン体の構成を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
この実施例では、ヘパリンと、コアとしてのポリ-L-リシンとを含むヘパリン体の構成を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
この実施例では、ヘパリンと、コアとしてのポリエチレンイミン(PEI)とを含むヘパリン体の構成を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
この実施例では、ヘパリンと、コアとしてのエチレンジアミン(EDA)とを含むヘパリン体の構成を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
実施例1〜6の自由端アルデヒドを含むヘパリン体をePTFE基板の表面に固定化し、ATIII活性を試験した。
実施例2、3、4、6で製造した自由端アルデヒド含有ヘパリン体を分析して絶対分子量を調べた。
この実施例では、基板表面へのヘパリンまたはヘパリン体の付着法を識別する検出法を示す。この実施例では特に、自由端アルデヒドを含む単点付着とカルボジイミド共役を含む多点付着を利用したePTFE基板の表面への固定化を通じたヘパリンとヘパリン体の付着を見る。
この実施例では、殺菌後の基板表面へのヘパリン体の付着法を識別する検出法示す。この実施例では特に、自由端アルデヒドを含む単点付着を利用してePTFE基板の表面に固定化させることを通じてヘパリン体を付着させた後に殺菌してホウ酸で洗浄する場合を見る。
この実施例では、ヘパリナーゼ-1で解重合したヘパリン体を強陰イオン交換高性能液体クロマトグラフィ(SAX-HPLC)でオリゴ糖マッピングすることを利用してヘパリン体の組成を明らかにする検出法を示す。
この実施例では、ヘパリナーゼ-1で解重合したヘパリン体を強陰イオン交換高性能液体クロマトグラフィ(SAX-HPLC)でオリゴ糖マッピングすることを利用して、表面に固定化されたヘパリン体の組成を明らかにする検出法を示す。
この実施例では、ヘパリンと、ポリ-L-リシンを含むコアとを含むヘパリン体の構造を記載する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいない。このヘパリン体は、イオン結合を通じて基板の表面に付着させるのに使用できる。
実施例13のヘパリン体をイオン結合を通じてePTFE基板の表面に固定化した。
この実施例では、ヘパリンとヘパリン体を表面に固定化するための共役法をあきらかにするための検出法を示す。この実施例では特に、ヘパリナーゼ-1で解重合した後に、固定化されたヘパリンまたはヘパリン体の表面にある表面結合不飽和ヘパリン断片または“節”の検出を見る。ヘパリナーゼ-1によるヘパリンの解重合には、ヘパリンの非還元性末端ウロン酸が酵素によって開裂し、さまざまな検出分子(例えばチオール-テルビウム蛍光分子)と反応させることができる4,5-不飽和誘導体になることが含まれる。イオン結合したヘパリンの負の対照(実施例14)が含まれる。
この実施例では、ヘパリンとアンチトロンビンIII(ATIII)の結合が多い、ヘパリンと、アミン含有フルオロポリマーを含むコアとを含むヘパリン体に関する本発明の一実施態様の構成と利用法を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
この実施例では、ヘパリンとアンチトロンビンIIIの結合が多い、ヘパリンと、アミン含有フルオロポリマーを含むコアとを含むヘパリン体に関する本発明の一実施態様の構成と利用法を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる、ヘパリン成分の長さに沿ったアルデヒドを含んでいる。
実施例7に記載した方法に従い、ヘパリンと、アミン含有フルオロポリマーを含むコアとを含む実施例16と17のヘパリン体をePTFE/PEI基板の表面に固定化したが、サンプルをEtOに曝露しなかった点が異なっている。実施例7に記載した方法に従ってATIII結合活性を測定した。
この実施例では、ヘパリンとアンチトロンビンIIIの結合が多い、ヘパリンと、アミン含有フルオロポリマーを含むコアとを含むヘパリン体に関する本発明の一実施態様の構成と利用法を説明する。このヘパリン体は、基板の表面に付着させるのに使用できる自由端アルデヒドを含んでいる。
Claims (21)
- 少なくとも1個のヘパリン分子を通じて基板の表面に結合したヘパリン体を含む医療用基板であって、該ヘパリン体が少なくとも1個のヘパリン分子と少なくとも1個のコア分子とを含み、該結合したヘパリン体がヘパリナーゼ感受性であり、かつ、該ヘパリン分子が該基板に対し、端点付着、ループ付着、端点アルデヒド付着またはアルデヒド付着により、該ヘパリンの長さに沿って付着している、医療用基板。
- 前記基板が、ポリエチレン、ポリウレタン、シリコーン、ポリアミド含有ポリマー、ポリプロピレン、ポリテトラフルオロエチレン、延伸ポリテトラフルオロエチレンおよび生体適合性金属からなる群から選ばれる、請求項1に記載の医療用基板。
- 前記基板が延伸ポリテトラフルオロエチレンである、請求項2に記載の医療用基板。
- 前記生体適合性金属がニチノールである、請求項2に記載の医療用基板。
- 前記基板が医療装置の一部品である、請求項1に記載の医療用基板。
- 前記医療装置が、グラフト、血管グラフト、ステント、ステント-グラフト、分岐グラフト、分岐ステント、分岐ステント-グラフト、パッチ、栓子、薬剤送達装置、カテーテル、心臓用リード線、バルーンおよび留置フィルタからなる群から選ばれる、請求項5に記載の医療用基板。
- 前記ステントを心臓、末梢、神経の用途に使用できる、請求項6に記載の医療用基板。
- 前記ステント-グラフトを心臓、末梢、神経の用途に使用できる、請求項6に記載の医療用基板。
- 前記コア分子が、環形、直線形、分岐形、樹枝形、Y字形、T字形または星形のいずれかである、請求項1に記載の医療用基板。
- 前記コア分子が、タンパク質、炭化水素、アミノグリコシド、多糖およびポリマーからなる群から選択される、請求項1に記載の医療用基板。
- 前記タンパク質が、アルブミン、コリスチンおよびポリリシンからなる群から選択される、請求項10に記載の医療用基板。
- 前記多糖が、シクロデキストリン、セルロースおよびキトサンからなる群から選択される、請求項10に記載の医療用基板。
- 前記ポリマーが、ポリエチレングリコール(PEG)およびテトラフルオロエチレンのコポリマーからなる群から選択される、請求項10に記載の医療用基板。
- 前記ヘパリンがウシ又はブタに由来する、請求項1に記載の医療用基板。
- ヘパリナーゼ処理の後、ヘパリンまたはその断片が前記基板上で検出されない、請求項1に記載の医療用基板。
- ヘパリナーゼ処理の後、ヘパリンまたはその断片が前記基板上で、ヘパリナーゼ処理の前よりも有意に低いレベルで検出される、請求項1に記載の医療用基板。
- 前記ヘパリンまたはその断片が、ヘパリンまたはその断片に結合する標識によって検出される、請求項15に記載の医療用基板。
- 前記ヘパリンまたはその断片に結合する前記標識が、染料、ポリクローナル抗体およびタンパク質からなる群から選ばれる、請求項17に記載の医療用基板。
- 前記染料がトルイジンブルーである、請求項18に記載の医療用基板。
- ヘパリナーゼ処理の後、わずかな量のトルイジンブルーが残留ヘパリンまたはその断片に結合するが、前記基板上では目視によって検出されない、請求項1に記載の医療用基板。
- ヘパリナーゼ処理の後、わずかな量のトルイジンブルーが残留ヘパリンまたはその断片に結合し、検出器の読みが、バックグラウンドのレベルであるか、またはヘパリン体なしの基板と比較してバックグラウンドと有意差がない、請求項1に記載の医療用基板。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/561,927 US8591932B2 (en) | 2009-09-17 | 2009-09-17 | Heparin entities and methods of use |
US12/561,927 | 2009-09-17 | ||
US12/579,308 US20110065085A1 (en) | 2009-09-17 | 2009-10-14 | Novel heparin entities and methods of use |
US12/579,308 | 2009-10-14 | ||
PCT/US2010/049078 WO2011035001A2 (en) | 2009-09-17 | 2010-09-16 | Novel heparin entities and methods of use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015183860A Division JP6290840B2 (ja) | 2009-09-17 | 2015-09-17 | 新規なヘパリン体とその利用法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013505070A JP2013505070A (ja) | 2013-02-14 |
JP2013505070A5 JP2013505070A5 (ja) | 2013-11-07 |
JP5814242B2 true JP5814242B2 (ja) | 2015-11-17 |
Family
ID=43730811
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012529895A Active JP5814242B2 (ja) | 2009-09-17 | 2010-09-16 | 新規なヘパリン体とその利用法 |
JP2015183860A Active JP6290840B2 (ja) | 2009-09-17 | 2015-09-17 | 新規なヘパリン体とその利用法 |
JP2017141575A Active JP6538767B2 (ja) | 2009-09-17 | 2017-07-21 | 新規なヘパリン体とその利用法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015183860A Active JP6290840B2 (ja) | 2009-09-17 | 2015-09-17 | 新規なヘパリン体とその利用法 |
JP2017141575A Active JP6538767B2 (ja) | 2009-09-17 | 2017-07-21 | 新規なヘパリン体とその利用法 |
Country Status (10)
Country | Link |
---|---|
US (3) | US8591932B2 (ja) |
EP (1) | EP2477668B1 (ja) |
JP (3) | JP5814242B2 (ja) |
CN (1) | CN102695530B (ja) |
AU (1) | AU2010295601B2 (ja) |
BR (1) | BR112012006144A2 (ja) |
CA (2) | CA2774494A1 (ja) |
ES (1) | ES2668220T3 (ja) |
RU (1) | RU2576803C2 (ja) |
WO (1) | WO2011035001A2 (ja) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8157951B2 (en) * | 2005-10-11 | 2012-04-17 | Applied Materials, Inc. | Capacitively coupled plasma reactor having very agile wafer temperature control |
US20130110137A1 (en) * | 2007-04-02 | 2013-05-02 | Ension, Inc. | Surface Treated Polymeric Synthetic Hernia Mesh Prosthesis, Surface Treated Sutures and Staples and Methods of Manufacturing the Same |
US9744033B2 (en) | 2011-04-01 | 2017-08-29 | W.L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US9554806B2 (en) | 2011-09-16 | 2017-01-31 | W. L. Gore & Associates, Inc. | Occlusive devices |
AR087037A1 (es) * | 2012-07-02 | 2014-02-12 | Consejo Nac Invest Cient Tec | Fibras amiloides de lisozima, soporte solido, biocatalizador y procedimientos |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
CN102796723A (zh) * | 2012-09-11 | 2012-11-28 | 深圳市海普瑞药业股份有限公司 | 肝素酶i的固定化方法 |
US9731017B2 (en) * | 2012-09-13 | 2017-08-15 | W. L. Gore & Associates, Inc. | Polytetrafluoroethylene co-polymer emulsions |
CN102888390B (zh) * | 2012-10-30 | 2014-09-03 | 深圳市海普瑞药业股份有限公司 | 肝素酶ⅲ的固定化方法 |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US9447304B2 (en) | 2013-03-14 | 2016-09-20 | W. L. Gore & Associates, Inc. | Coating for a surface |
CN105263536B (zh) * | 2013-03-15 | 2017-10-31 | 巴克斯特国际公司 | 活性剂在衬底上的固定 |
EP3003413B1 (en) * | 2013-06-07 | 2017-12-13 | Baxter International Inc. | Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
WO2015048566A1 (en) * | 2013-09-26 | 2015-04-02 | The General Hospital Corporation | Methods of isolating extracellular vesicles |
US9504565B2 (en) | 2013-12-06 | 2016-11-29 | W. L. Gore & Associates, Inc. | Asymmetric opening and closing prosthetic valve leaflet |
JP6520706B2 (ja) * | 2014-02-12 | 2019-05-29 | 東レ株式会社 | 人工血管 |
US11839698B2 (en) | 2014-03-13 | 2023-12-12 | W. L. Gore & Associates, Inc. | Drug composition and coating |
EP3182929B1 (en) | 2014-08-18 | 2023-08-09 | Edwards Lifesciences Corporation | Frame with integral sewing cuff for prosthetic valves |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
EP3294150B1 (en) | 2015-05-14 | 2021-12-15 | W. L. Gore & Associates, Inc. | Devices for occlusion of an atrial appendage |
EP3095509A1 (en) | 2015-05-18 | 2016-11-23 | Defymed | Membranes functionalized with heparin for bioartificial organs |
US10525376B2 (en) | 2015-07-20 | 2020-01-07 | W. L. Gore & Associates, Inc. | Affinity chromatography devices |
US10526367B2 (en) | 2015-07-20 | 2020-01-07 | W. L. Gore & Associates, Inc. | Affinity chromatography devices |
WO2017132642A1 (en) * | 2016-01-29 | 2017-08-03 | The Regents Of The University Of California | A wearable sensor, and method, to monitor anti-coagulation therapy |
KR102216602B1 (ko) | 2016-04-08 | 2021-02-17 | 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 | 친화성 크로마토그래피 장치 |
US11173235B2 (en) | 2016-07-15 | 2021-11-16 | Cook Regentec Llc | Nitrite eluting devices and methods of use thereof |
RU2650667C1 (ru) * | 2016-12-02 | 2018-04-16 | Федеральное государственное бюджетное учреждение "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Национального исследовательского центра "Курчатовский институт" (НИЦ "Курчатовский институт" - ГосНИИгенетика) | Мутантная рекомбинантная гепариназа I с повышенной удельной активностью из Pedobacter heparinus, фрагмент ДНК, кодирующий указанную гепариназу |
WO2019055577A1 (en) | 2017-09-12 | 2019-03-21 | W. L. Gore & Associates, Inc. | SHEET FRAME FIXATION FOR PROSTHETIC VALVES |
EP3687451B1 (en) | 2017-09-27 | 2023-12-13 | Edwards Lifesciences Corporation | Prosthetic valve with expandable frame |
AU2018342223B2 (en) | 2017-09-27 | 2021-04-01 | Edwards Lifesciences Corporation | Prosthetic valves with mechanically coupled leaflets |
EP3694445A1 (en) | 2017-10-13 | 2020-08-19 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve and delivery system |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
US11154397B2 (en) | 2017-10-31 | 2021-10-26 | W. L. Gore & Associates, Inc. | Jacket for surgical heart valve |
CA3178262A1 (en) | 2017-10-31 | 2019-05-09 | W. L. Gore & Associates, Inc. | Transcatheter deployment systems and associated methods |
CN114831777A (zh) | 2017-10-31 | 2022-08-02 | W.L.戈尔及同仁股份有限公司 | 假体心脏瓣膜 |
CN111295158A (zh) | 2017-10-31 | 2020-06-16 | W.L.戈尔及同仁股份有限公司 | 医用瓣膜和促进组织向内生长的瓣叶 |
WO2019203898A1 (en) * | 2018-04-20 | 2019-10-24 | Ension, Inc. | Engineered heparin bioactive matrix for clinical application of blood contacting surface and method of manufacturing the same |
EP3846867A1 (en) | 2018-09-06 | 2021-07-14 | Biomodics APS | A medical tubular device |
CA3118664C (en) | 2018-11-05 | 2023-02-14 | Matthew A. Johnson | Spiral wound protein separation device |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
CN109709292A (zh) * | 2018-12-29 | 2019-05-03 | 贵州金玖生物技术有限公司 | 一种肝素检测试剂盒及其应用 |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
CN110917410B (zh) * | 2019-11-14 | 2020-11-24 | 浙江大学 | 一种基于双层异相结构的心血管支架涂层及其制备方法 |
CN111826418A (zh) * | 2020-08-28 | 2020-10-27 | 保定天岳生物工程有限公司 | 一种抗凝血酶iii测定试剂盒 |
US20240042348A1 (en) | 2020-09-11 | 2024-02-08 | W. L. Gore & Associates, Inc. | Affinity chromatography devices containing a heat treated fibrillated polymer membrane and manifolds containing the same |
WO2022225792A1 (en) | 2021-04-19 | 2022-10-27 | W. L. Gore & Associates, Inc. | Electrochemical analyte biosensors, associated compositions of matter, and methods for making and using same |
CN113786518A (zh) * | 2021-09-15 | 2021-12-14 | 海思盖德(苏州)生物医学科技有限公司 | 用于医用材料表面修饰的复合涂层的制备方法 |
EP4218980A1 (en) | 2022-02-01 | 2023-08-02 | W.L. Gore & Associates Inc. | Affinity chromatography devices containing a heat treated fibrillated polymer membrane for the separation of mrna and viral vectors from an aqueous mixture |
EP4218981A1 (en) | 2022-02-01 | 2023-08-02 | W. L. Gore & Associates, Inc. | Affinity chromatography devices containing a fibrillated polymer membrane for the separation of mrna and viral vectors from an aqueous mixture |
CN115998963B (zh) * | 2023-03-22 | 2023-07-21 | 上海发微医用材料有限公司 | 抗凝涂层及其制备方法、应用 |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA962021A (en) | 1970-05-21 | 1975-02-04 | Robert W. Gore | Porous products and process therefor |
US4415490A (en) | 1979-07-24 | 1983-11-15 | Nippon Zeon Co., Ltd. | Non-thrombogenic material |
US4329383A (en) | 1979-07-24 | 1982-05-11 | Nippon Zeon Co., Ltd. | Non-thrombogenic material comprising substrate which has been reacted with heparin |
US4326532A (en) | 1980-10-06 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Antithrombogenic articles |
US4526714A (en) | 1982-12-13 | 1985-07-02 | Cordis Europa N.V. | Conjugates of anticoagulant and protein |
US4678671A (en) | 1981-12-15 | 1987-07-07 | Cordis Europa N.V. | Conjugates of anticoagulant and protein |
SE456347B (sv) | 1982-02-09 | 1988-09-26 | Ird Biomaterial Ab | Ytmodifierat fast substrat samt forfarande for framstellning derav |
SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
US4600652A (en) | 1985-04-01 | 1986-07-15 | Warner-Lambert Company | Permanently bonded antithrombogenic polyurethane surface |
IT1213023B (it) | 1986-01-16 | 1989-12-07 | Rolando Barbucci | Materiale capace di adsorbire stabilmente elevate quantita' di eparina, e suo procedimento di preparazione. |
SE452551B (sv) | 1986-05-27 | 1987-12-07 | Camurus Ab | Artikel belagd med heparinbaserat material samt forfarande for dess framstellning |
US4745180A (en) | 1986-06-27 | 1988-05-17 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using heparin fragments |
US5527524A (en) | 1986-08-18 | 1996-06-18 | The Dow Chemical Company | Dense star polymer conjugates |
US5308617A (en) | 1988-08-10 | 1994-05-03 | Halzyme Ltd. | Protein heparin conjugates |
US5130143A (en) | 1988-11-04 | 1992-07-14 | The Research Foundation Of State University Of New York | Use of a low affinity-heparin fraction in conjunction with t-pa for thrombolytic therapy |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5032666A (en) | 1989-06-19 | 1991-07-16 | Becton, Dickinson And Company | Amine rich fluorinated polyurethaneureas and their use in a method to immobilize an antithrombogenic agent on a device surface |
US5049403A (en) | 1989-10-12 | 1991-09-17 | Horsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
US5213898A (en) | 1989-10-12 | 1993-05-25 | Norsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
WO1993005825A1 (en) | 1991-09-20 | 1993-04-01 | Baxter International Inc. | Processes for reducing the thrombogenicity of biomaterials |
SE470006B (sv) * | 1991-09-26 | 1993-10-25 | Corline Systems Ab | Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet |
US5532311A (en) | 1995-02-01 | 1996-07-02 | Minnesota Mining And Manufacturing Company | Process for modifying surfaces |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US5583213A (en) | 1995-05-12 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Process to activate sulfated polysaccharides |
US5767108A (en) | 1995-08-22 | 1998-06-16 | Medtronic, Inc. | Method for making improved heparinized biomaterials |
US5679659A (en) | 1995-08-22 | 1997-10-21 | Medtronic, Inc. | Method for making heparinized biomaterials |
US7045585B2 (en) | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
NZ325248A (en) | 1995-12-23 | 1999-09-29 | Pfizer Res & Dev | Quinoline and quinazoline compounds useful in therapy |
US5922690A (en) | 1996-04-25 | 1999-07-13 | Van Gorp; Cornelius L. | Dermatan disulfate, an inhibitor of thrombin generation and activation |
GB9608882D0 (en) | 1996-04-30 | 1996-07-03 | Luthra Ajay K | Non-thrombogenic and anti-thrombogenic polymers |
US5876433A (en) | 1996-05-29 | 1999-03-02 | Ethicon, Inc. | Stent and method of varying amounts of heparin coated thereon to control treatment |
US5916585A (en) | 1996-06-03 | 1999-06-29 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto biodegradable polymers |
US5914182A (en) | 1996-06-03 | 1999-06-22 | Gore Hybrid Technologies, Inc. | Materials and methods for the immobilization of bioactive species onto polymeric substrates |
US5728751A (en) | 1996-11-25 | 1998-03-17 | Meadox Medicals, Inc. | Bonding bio-active materials to substrate surfaces |
JPH114883A (ja) | 1997-06-18 | 1999-01-12 | Toray Ind Inc | 抗血栓性医療材料 |
JP2003506310A (ja) | 1997-10-07 | 2003-02-18 | リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | ヘパリン及びアデノシドa2アゴニストの組合せで、又はアデノシンでの閉塞性末梢血管疾患及び冠状動脈疾患の治療 |
FI974321A0 (fi) | 1997-11-25 | 1997-11-25 | Jenny Ja Antti Wihurin Rahasto | Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa |
WO2000015144A1 (en) | 1998-06-10 | 2000-03-23 | Advanced Bypass Technologies, Inc. | Aortic aneurysm treatment systems |
GB9814420D0 (en) | 1998-07-03 | 1998-09-02 | Cancer Res Campaign Tech | Sequence analysis of saccharide material |
US6248127B1 (en) * | 1998-08-21 | 2001-06-19 | Medtronic Ave, Inc. | Thromboresistant coated medical device |
NO984143L (no) | 1998-09-09 | 2000-03-10 | Norsk Hydro As | Ny prosess for å fremstille overflatemodifiserende stoffer |
CA2371462C (en) | 1999-04-22 | 2009-09-15 | Jason C. Schense | Modified protein matrices |
US6936066B2 (en) | 1999-11-19 | 2005-08-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Complaint implantable medical devices and methods of making same |
US7736687B2 (en) | 2006-01-31 | 2010-06-15 | Advance Bio Prosthetic Surfaces, Ltd. | Methods of making medical devices |
SE515295C2 (sv) * | 1999-11-23 | 2001-07-09 | Medicarb Ab | Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat |
GB9928956D0 (en) | 1999-12-07 | 2000-02-02 | Malik Navid | Internally supported biomimetic coating systems |
US6518244B2 (en) | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
US7875283B2 (en) | 2000-04-13 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Biodegradable polymers for use with implantable medical devices |
AU5574101A (en) | 2000-04-28 | 2001-11-12 | Univ Emory | Decellularized vascular prostheses |
DE60114406T2 (de) | 2000-05-12 | 2006-08-03 | Cordis Corp., Miami Lakes | Wirkstoffabgabesysteme zur behandlung von gefässerkrankungen |
US20050059068A1 (en) | 2001-05-23 | 2005-03-17 | Stratagene California | Compositions and methods using dendrimer-treated microassays |
US6787179B2 (en) | 2001-06-29 | 2004-09-07 | Ethicon, Inc. | Sterilization of bioactive coatings |
AR038269A1 (es) | 2002-01-09 | 2005-01-12 | Novartis Ag | Articulos polimericos que tienen un recubrimiento lubrico, y metodo para fabricarlos |
US20030135195A1 (en) | 2002-01-16 | 2003-07-17 | Oscar Jimenez | Highly lubricious hydrophilic coating utilizing dendrimers |
NZ536330A (en) * | 2002-05-09 | 2007-08-31 | Hemoteq Ag | Medical devices such as stents comprising haemocompatible coating, production and use thereof |
JP2005044408A (ja) * | 2003-07-24 | 2005-02-17 | Pioneer Electronic Corp | 光集積装置および光ピックアップ装置 |
EP1668359A2 (en) | 2003-08-12 | 2006-06-14 | University of Utah Research Foundation | Heparin binding proteins: sensors for heparin detection |
CN1255189C (zh) * | 2003-10-20 | 2006-05-10 | 北京理工大学 | 一种抗凝血性不溶性丝素材料的制备方法 |
CN1256991C (zh) * | 2003-12-27 | 2006-05-24 | 重庆大学 | 聚醚氨酯基肝素化高分子液晶抗凝血复合材料制备方法 |
CA2563069A1 (en) | 2004-04-06 | 2005-10-27 | Surmodics, Inc. | Coating compositions for bioactive agents |
GB0422877D0 (en) | 2004-10-14 | 2004-11-17 | Univ Glasgow | Bioactive polymers |
US20060204533A1 (en) | 2005-03-14 | 2006-09-14 | Biotegra, Inc. | Drug Delivery Compositions and Related Methods |
US7767420B2 (en) | 2005-11-03 | 2010-08-03 | Momenta Pharmaceuticals, Inc. | Heparan sulfate glycosaminoglycan lyase and uses thereof |
US20070212387A1 (en) | 2006-03-08 | 2007-09-13 | Sahajanand Medical Technologies Pvt. Ltd. | Coatings for implantable medical devices |
JP2009545333A (ja) | 2006-05-12 | 2009-12-24 | ゴア エンタープライズ ホールディングス,インコーポレイティド | 物理的操作または殺菌の後に大きな生物活性を有する固定化された生物活性物質 |
US8986713B2 (en) | 2006-05-12 | 2015-03-24 | W. L. Gore & Associates, Inc. | Medical device capable of being compacted and expanded having anti-thrombin III binding activity |
US20080279909A1 (en) | 2006-05-12 | 2008-11-13 | Cleek Robert L | Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization |
US9114194B2 (en) | 2006-05-12 | 2015-08-25 | W. L. Gore & Associates, Inc. | Immobilized biologically active entities having high biological activity following mechanical manipulation |
US20100028402A1 (en) | 2006-10-25 | 2010-02-04 | Marina Dobrovolskaia | Nanoparticle-based anticoagulant |
DE102008021894A1 (de) | 2008-05-02 | 2009-11-05 | Biotronik Vi Patent Ag | Implantat umfassend eine Oberfläche mit verringerter Thrombogenität |
GB0816783D0 (en) | 2008-09-15 | 2008-10-22 | Carmeda Ab | Immobilised biological entities |
-
2009
- 2009-09-17 US US12/561,927 patent/US8591932B2/en active Active
- 2009-10-14 US US12/579,308 patent/US20110065085A1/en not_active Abandoned
-
2010
- 2010-09-16 CA CA2774494A patent/CA2774494A1/en not_active Abandoned
- 2010-09-16 CA CA2838352A patent/CA2838352C/en active Active
- 2010-09-16 CN CN201080051584.5A patent/CN102695530B/zh active Active
- 2010-09-16 EP EP10755304.2A patent/EP2477668B1/en active Active
- 2010-09-16 WO PCT/US2010/049078 patent/WO2011035001A2/en active Application Filing
- 2010-09-16 ES ES10755304.2T patent/ES2668220T3/es active Active
- 2010-09-16 JP JP2012529895A patent/JP5814242B2/ja active Active
- 2010-09-16 BR BR112012006144A patent/BR112012006144A2/pt not_active IP Right Cessation
- 2010-09-16 AU AU2010295601A patent/AU2010295601B2/en active Active
- 2010-09-16 RU RU2012115097/15A patent/RU2576803C2/ru active
-
2014
- 2014-01-14 US US14/154,923 patent/US20140128544A1/en not_active Abandoned
-
2015
- 2015-09-17 JP JP2015183860A patent/JP6290840B2/ja active Active
-
2017
- 2017-07-21 JP JP2017141575A patent/JP6538767B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP2477668B1 (en) | 2018-02-07 |
US8591932B2 (en) | 2013-11-26 |
EP2477668A2 (en) | 2012-07-25 |
JP2013505070A (ja) | 2013-02-14 |
CA2774494A1 (en) | 2011-03-24 |
AU2010295601A1 (en) | 2012-05-10 |
CA2838352A1 (en) | 2011-03-24 |
US20110064781A1 (en) | 2011-03-17 |
RU2576803C2 (ru) | 2016-03-10 |
JP2016005773A (ja) | 2016-01-14 |
WO2011035001A3 (en) | 2011-08-18 |
AU2010295601B2 (en) | 2014-02-13 |
RU2012115097A (ru) | 2013-10-27 |
BR112012006144A2 (pt) | 2016-06-28 |
JP6538767B2 (ja) | 2019-07-03 |
WO2011035001A2 (en) | 2011-03-24 |
CA2838352C (en) | 2018-04-24 |
WO2011035001A8 (en) | 2012-04-19 |
CN102695530B (zh) | 2018-11-30 |
ES2668220T3 (es) | 2018-05-17 |
US20140128544A1 (en) | 2014-05-08 |
JP2017192801A (ja) | 2017-10-26 |
CN102695530A (zh) | 2012-09-26 |
US20110065085A1 (en) | 2011-03-17 |
JP6290840B2 (ja) | 2018-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6290840B2 (ja) | 新規なヘパリン体とその利用法 | |
JP6962901B2 (ja) | 物理的操作または殺菌の後に大きな生物活性を有する固定化された生物活性物質 | |
JP6122052B2 (ja) | 固定化生物学的実体 | |
JP6239015B2 (ja) | 高度の生物活性を持つ固定化された生物活性物質 | |
JP2020108864A (ja) | 固定された生物学的実体 | |
JP2021514881A (ja) | 生物学的実体の固定方法の改善 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130917 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130917 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140930 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20141226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150331 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20150702 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150818 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150917 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5814242 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |